Skip to main content
Log in

A combined extract containing Schisandra chinensis (SCE) reduced hepatic triglyceride accumulation in rats fed a high-sucrose diet

  • Research Article
  • Published:
Food Science and Biotechnology Aims and scope Submit manuscript

A Correction to this article was published on 26 December 2023

This article has been updated

Abstract

Excessive hepatic lipid accumulation is closely linked to inflammation, insulin resistance, and metabolic syndromes. We hypothesized that a combined extract containing Schisandra chinensis (SCE) could alleviate hepatic lipid accumulation. Male Sprague–Dawley rats fed a high-sucrose diet (HSD) were randomly assigned to three groups (n = 6): normal diet (ND), HSD (60% kcal from sucrose), and HSD + SCE (HSD with 2.44% SCE). Liquid chromatography–tandem mass spectrometry revealed that SCE contains chlorogenic acid (5.514 ± 0.009 mg/g) and schisandrin (0.179 ± 0.002 mg/g) as bioactive components. SCE did not alter the body weight, fat mass, lean mass, or glucose levels. Strikingly, SCE effectively reduced the plasma triglyceride (TG) and hepatic TG levels compared to the HSD group. Adiposity reduction is due to decreased activity of hepatic de novo lipogenic enzymes. These results indicated that SCE has nutraceutical potential for the prevention and treatment of hepatic steatosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Change history

References

  • Andrikopoulos S, Blair AR, Deluca N, Fam BC, Proietto J. Evaluating the glucose tolerance test in mice. American Journal of Physiology-Endocrinology and Metabolism. 295: 1323-1332 (2008)

    Article  Google Scholar 

  • Angulo P. Nonalcoholic fatty liver disease. New England Journal of Medicine. 346(16): 1221-1231 (2002)

    Article  CAS  PubMed  Google Scholar 

  • Arca M, Veronesi C, D’Erasno L, Borghi C, Colivicchi F, Ferrari GMD, Desideri G, Pontremoli R, Temporelli PL, Perrone V, Esposti LD. Association of hypertriglyceridemia with all‐cause mortality and atherosclerotic cardiovascular events in a low‐risk Italian population: the TG‐REAL retrospective cohort analysis. Journal of American Heart Association. 9(19): e015801 (2020)

    Article  CAS  Google Scholar 

  • Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 55(6): 2005-23 (2012)

    Article  PubMed  Google Scholar 

  • Cho AS, Jeon SM, Kim MJ, Yeo J, Seo KI, Choi MS, Lee MK. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food and Chemical Toxicology. 48(3): 937-43 (2010)

    Article  CAS  PubMed  Google Scholar 

  • Chung MY, Shin EJ, Choi HK, Kim SH, Sung MJ, Park JH, Hwang JT. Schisandra chinensis berry extract protects against steatosis by inhibiting histone acetylation in oleic acid-treated HepG2 cells and in the livers of diet-induced obese mice. Nutrition Research. 46: 1-10 (2017)

    Article  CAS  PubMed  Google Scholar 

  • Cusi K, Orsak B, Bril F, Lomonaco R, Hecht J, Ortiz-Lopez C, Tio F, Hardies J, Darland C, Musi N, Webb A, Portillo-Sanchez P. Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial. Annals of Internal Medicine. 165(5): 305-315 (2016)

    Article  PubMed  Google Scholar 

  • Diehl AM, Day C. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis. New England Journal of Medicine. 377(21): 2063-2072 (2017)

    Article  CAS  PubMed  Google Scholar 

  • Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. Journal of Clinical Investigation. 115(5): 1343-1351 (2005)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Farah A, Monteiro M, Donangelo CM, Lafay S. Chlorogenic acids from green coffee extract are highly bioavailable in humans. Journal of Nutrition. 138(12): 2309-2315 (2008)

    Article  CAS  PubMed  Google Scholar 

  • Go GW, Srivastava R, Hernandez-Ono A, Gang G, Smith SB, Booth CJ, Ginsberg HN, Mani A. The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue. Cell Metabolism. 19(2): 209-20 (2014)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Guo LY, Hung TM, Bae KH, Shin EM, Zhou HY, Hong YN, Kang SS, Kim HP, Kim YS. Anti-inflammatory effects of schisandrin isolated from the fruit of Schisandra chinensis Baill. European Journal of Pharmacology. 591(1-3): 293-9 (2008)

    Article  CAS  PubMed  Google Scholar 

  • Heeren J, Scheja L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Molecular Metabolism. 50: 101238 (2021)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Huang W, Dedousis N, O’Doherty RM. Hepatic steatosis and plasma dyslipidemia induced by a high-sucrose diet are corrected by an acute leptin infusion. Journal of Applied Physiology. 102(6): 2260-2265 (2007)

    Article  CAS  PubMed  Google Scholar 

  • Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cellular and Molecular Life Sciences. 75(18): 3313-3327 (2018)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jang MK, Nam JS, Kim JH, Yun YR, Han CW, Kim BJ, Jeong HS, Ha KT, Jung MH. Schisandra chinensis extract ameliorates nonalcoholic fatty liver via inhibition of endoplasmic reticulum stress. Journal of Ethnopharmacology. 185: 96-104 (2016)

    Article  PubMed  Google Scholar 

  • Jeong EJ, Lee WJ, Kim KY. Effects of Schizandra chinensis Extract on the Growth of Intestinal Bacteria Related with Obesity. Korean Journal of Food Science and Technology. 41 (2009)

    Article  Google Scholar 

  • Jeong MJ, Kim SR, Jung UJ. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet. Nutrition Research. 64: 64-71 (2019)

    Article  CAS  PubMed  Google Scholar 

  • Jeong EW, Park GR, Kim J, Baek Y, Go GW, Lee HG. Whey Proteins-Fortified Milk with Adjusted Casein to Whey Proteins Ratio Improved Muscle Strength and Endurance Exercise Capacity without Lean Mass Accretion in Rats. Foods. 11(4): 574 (2022)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kanazawa M, Xue CY, Kageyama H, Suzuki E, Ito R, Namba Y, Osaka T, Kimura S, Inoue S. Effects of a high-sucrose diet on body weight, plasma triglycerides, and stress tolerance. Nutrition Reviews. 61: S27-33 (2003)

    Article  PubMed  Google Scholar 

  • Kang EY, Kim HK, Jung JY, Kim JH, Woo TK, Choi JI, Kim JH, Ahn C, Lee HG, Go GW. Combined Extract of Leonurus japonicus Houtt, Eclipta prostrata L., and Pueraria lobata Ohwi Improved Hot Flashes and Depression in an Ovariectomized Rat Model of Menopause. Foods. 10(1): 180 (2021)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kawano Y, Cohen DE. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. Journal of Gastroenterology. 48(4): 434-441 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim SI, Sim KH, Ju SY, Han YS. A Study of Antioxidative and Hypoglycemic Activities of Omija (Schizandra chinensis Baillon) Extract under Variable Extract Conditions. The Korean Journal of Food And Nutrition. 22(1): 41-47 (2009)

    CAS  Google Scholar 

  • Kim H, Choe JH, Choi JH, et al. Medium-Chain Enriched Diacylglycerol (MCE-DAG) Oil Decreases Body Fat Mass in Mice by Increasing Lipolysis and Thermogenesis in Adipose Tissue. Lipids. 52(8): 665-673 (2017)

    Article  CAS  PubMed  Google Scholar 

  • Kim HK, Jeong J, Kang EY, Go GW. Red Pepper (Capsicum annuum L.) Seed Extract Improves Glycemic Control by Inhibiting Hepatic Gluconeogenesis via Phosphorylation of FOXO1 and AMPK in Obese Diabetic db/db Mice. Nutrients. 12(9):2546 (2020)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kishi K, Goto M, Tsuru Y, Hori M. Noninvasive monitoring of muscle atrophy and bone metabolic disorders using dual-energy X-ray absorptiometry in diabetic mice. Experimental Animals. 72(1): 68-76 (2023)

    Article  CAS  PubMed  Google Scholar 

  • Kwon HJ, Park CS. Biological Activities of Extracts from Omija(Schizandra chinensis Baillon). Korean Journal of Food Preservation. 15(4): 587-592 (2008)

    Google Scholar 

  • Lally JSV, Ghoshal S, DePeralta DK, Moaven O, Wei L, Masia R, Erstad DJ, Fujiwara N, Leong V, Houde VP, Anagnostopoulos AE, Wang A, Broadfield LA, Ford RJ, Foster RA, Bates J, Sun H, Wang T, Liu H, Ray AS, Saha AK, Greenwood J, Bhat S, Harriman G, Miao W, Rocnik JL, Westlin WF, Muti P, Tsakiridis T, Harwood HJ Jr, Kapeller R, Hoshida Y, Tanabe KK, Steinberg GR, Fuchs BC. Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma. Cell Metabolism. 29(1): 174-182.e5 (2019)

    Article  CAS  PubMed  Google Scholar 

  • Lazarus JV, Mark HE, Anstee QM, Arab JP, Batterham RL, Castera L, Cortez-Pinto H, Crespo J, Cusi K, Dirac MA, Francque S, George J, Hagström H, Huang TT, Ismail MH, Kautz A, Sarin SK, Loomba R, Miller V, Newsome PN, Ninburg M, Ocama P, Ratziu V, Rinella M, Romero D, Romero-Gómez M, Schattenberg JM, Tsochatzis EA, Valenti L, Wong VW, Yilmaz Y, Younossi ZM, Zelber-Sagi S; NAFLD Consensus Consortium. Advancing the global public health agenda for NAFLD: a consensus statement. Nature Reviews Gastroenterology & Hepatology. 19(1): 60-78 (2022a)

    Article  CAS  Google Scholar 

  • Lazarus JV, Mark HE, Villota-Rivas M, Palayew A, Carrieri P, Colombo M, Ekstedt M, Esmat G, George J, Marchesini G, Novak K, Ocama P, Ratziu V, Razavi H, Romero-Gómez M, Silva M, Spearman CW, Tacke F, Tsochatzis EA, Yilmaz Y, Younossi ZM, Wong VW, Zelber-Sagi S, Cortez-Pinto H, Anstee QM; NAFLD policy review collaborators. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge? Journal of Hepatology. 76(4): 771-780 (2022b)

    Article  CAS  PubMed  Google Scholar 

  • Lee BW, Lee YH, Park CY, Rhee EJ, Lee WY, Kim NH, Choi KM, Park KG, Choi YK, Cha BS, Lee DH. Non-Alcoholic fatty liver disease in patients with type 2 diabetes mellitus: a position statement of the fatty liver research group of the korean diabetes association. Diabetes and Metabolism Journal. 44(3): 382-401 (2020)

    Article  PubMed  PubMed Central  Google Scholar 

  • Li L, Su C, Chen X, Wang Q, Jiao W, Luo H, Tang J, Wang W, Li S, Guo S. Chlorogenic Acids in Cardiovascular Disease: A Review of Dietary Consumption, Pharmacology, and Pharmacokinetics. Journal of Agricultural and Food Chemistry. 68(24): 6464-6484 (2020)

    Article  CAS  PubMed  Google Scholar 

  • Miller M, Stone NJ, Ballantyne C, Bittner C, Criqui MH, Ginsberg HN, Goldberg AC, Howard WJ, Jacobson MS, Kris-Etherton PM, Lennie TA, Levi M, Mazzone T, Pennathur S. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 123(20): 2292-2333 (2011)

    Article  PubMed  Google Scholar 

  • Minehira K, Young SG, Villanueva CJ, Yetukuri L, Oresic M, Hellerstein MK, Farese RV Jr, Horton JD, Preitner F, Thorens B, Tappy L. Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice. Journal of Lipid Research. 49(9): 2038-44 (2008)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mir BA, Majeed T, Chauhan A. Nonalcoholic Fatty Liver Disease. New England Journal of Medicine. 386(3): 295 (2022)

    PubMed  Google Scholar 

  • Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. American Journal of Physiology-Endocrinology and Metabolism. 294: 15-26 (2008)

    Article  Google Scholar 

  • Naguib G, Morris N, Yang S, Fryzek N, Haynes-Williams V, Huang WA, Norman-Wheeler J, Rotman Y. Dietary fatty acid oxidation is decreased in non-alcoholic fatty liver disease: A palmitate breath test study. Liver International. 40(3): 590-597 (2020)

    Article  CAS  PubMed  Google Scholar 

  • Nature Medicine. Cutting out the liver fat. 23(12):1385 (2017)

  • Nazarian A, Cory E, Müller R, Snyder BD. Shortcomings of DXA to assess changes in bone tissue density and microstructure induced by metabolic bone diseases in rat models. Osteoporos International. 20(1): 123-132 (2009)

    Article  CAS  Google Scholar 

  • Ong KW, Hsu A, Tan BKH. Chlorogenic acid stimulates glucose transport in skeletal muscle via AMPK activation: A contributor to the beneficial effects of coffee on diabetes. PLoS One. 7(3) (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Park JH, Yoon J. Schizandrin inhibits fibrosis and epithelial-mesenchymal transition in transforming growth factor-β1-stimulated AML12 cells. International Immunopharmacology. 25(2): 276-84 (2015)

    Article  CAS  PubMed  Google Scholar 

  • Park HJ, Cho, JY, Kim MK, Koh, PO, Cho KW, Kim CH, Lee KS, Chung BY, Kim GS, Cho JH. Anti-obesity effect of Schisandra chinensis in 3T3-L1 cells and high fat diet-induced obese rats. Food Chemistry. 134(1): 227–234 (2012a)

    Article  CAS  Google Scholar 

  • Park SY, Hwang HY, Seo EA, Kwon KB, Ryu DG. Inhibition effects of Galla chinenisis extract on adipocyte differentiation in OP9 cells. Journal of Physiology & Pathology in Korean Medicine. 26(4): 455-461 (2012b)

    Google Scholar 

  • Pathak MP, Pathak K, Saikia R, Gogoi U, Patowary P, Chattopadhyay P, Das A. Therapeutic potential of bioactive phytoconstituents found in fruits in the treatment of non-alcoholic fatty liver disease: A comprehensive review. Heliyon. 9(4): e15347 (2023)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism. 92: 82-97 (2019)

    Article  CAS  PubMed  Google Scholar 

  • Roden M. Diabetes mellitus – definition, klassifikation und diagnose. Wien Klin Wochenschr. 128: S37-40 (2016)

    Article  PubMed  Google Scholar 

  • Samuel VT, Shulman GI. Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Ceramides. New England Journal of Medicine. 381(19): 1866-1869 (2019)

    Article  PubMed  Google Scholar 

  • Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A, Halavaara J, Yki-Järvinen H. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. Journal of Clinical Endocrinology and Metabolism. 87(7): 3023-3028 (2002)

    Article  PubMed  Google Scholar 

  • Song YO, Lee SJ, Park HJ, Jang SH, Chung BY, Song YM, Kim GS, Cho JH. Hepatoprotective effect of Schisandra chinensis on high-fat diet-induced fatty liver in rats. Korean Journal of Veterinary Service. The Korean Society of Veterinary Service. 36(1): 45-52 (2013)

    Article  Google Scholar 

  • H.V. S, K V, Patel D, K S. Biomechanism of chlorogenic acid complex mediated plasma free fatty acid metabolism in rat liver. BMC Complementary and Alternative Medicine. 16(1): 274 (2016)

    Article  Google Scholar 

  • Sun JH, Liu X, Cong LX, Li H, Zhang CY, Chen JG, Wang CM. Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice. Lipids in Health and Disease. 16(1): 145 (2017)

    Article  PubMed  PubMed Central  Google Scholar 

  • Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. New England Journal of Medicine. 363(14): 1341-50 (2010)

    Article  CAS  PubMed  Google Scholar 

  • Vilar-Gomez E, Yasells-Garcia A, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, Villa-Jimenez O, Friedman SL, Diago M, Romero-Gomez M. Development and validation of a noninvasive prediction model for nonalcoholic steatohepatitis resolution after lifestyle intervention. Hepatology. 63(6): 1875-1887 (2016)

    Article  CAS  PubMed  Google Scholar 

  • Wang S, Song K, Srivastava R, Dong C, Go GW, Li N, Iwakiri Y, Mani A. Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a. The FASEB Journal. 29(8): 3436-45 (2015)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang Z, Lam KL, Hu J, Ge S, Zhou A, Zheng B, Zeng S, Lin S. Chlorogenic acid alleviates obesity and modulates gut microbiota in high-fat-fed mice. Food Science and Nutrition. 7(2): 579-588 (2019)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang LL, Zhang PH, Yan HH. Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis. Frontiers in Nutrition. 10: 1014010 (2023)

    Article  PubMed  PubMed Central  Google Scholar 

  • Wong SK, Chin KY, Suhaimi FH, Fairus A, Ima-Nirwana S. Animal models of metabolic syndrome: a review. Nutrition & Metabolism. 13: 65 (2016)

    Article  Google Scholar 

  • You YL, Lee JY, Choi HS. Schisandra chinensis‑derived gomisin C suppreses lipid accumulation by JAK2‑STAT signaling in adipocyte. Food Science and Biotechnology. 32: 1225-1233 (2023)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 64(1): 73-84 (2016)

    Article  PubMed  Google Scholar 

  • Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 77(4): 1335-1347 (2023)

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Cao Lei or Gwang-woong Go.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 4832 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, H., Kang, E.Y., Lee, J. et al. A combined extract containing Schisandra chinensis (SCE) reduced hepatic triglyceride accumulation in rats fed a high-sucrose diet. Food Sci Biotechnol 33, 1449–1457 (2024). https://doi.org/10.1007/s10068-023-01464-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10068-023-01464-1

Keywords

Navigation